Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy discusses the success of targeted drugs such inotuzumab ozogamicin in adult acute lymphoblastic leukemia (ALL) and suggests that physicians should rapidly adpot these new drugs for clinical use.
Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.